Press-release for stocks for immunitybio inc

Prices are updated after-hours

Amyris, Inc. Reports Third Quarter 2021 Financial Results
Published: 2021-11-08 (Crawled : 23:00) - prnewswire.com
IBRX | $5.175 -5.74% 3.8M

| -35.56% | O: 0.0% H: 0.94% C: -4.93%
AMRS | $0.05 -21.88% -16.36% 47M

| -99.51% | O: -22.5% H: 0.0% C: 0.0%
financial results results

Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
IBRX | $5.175 -5.74% 3.8M

| -36.9% | O: -1.84% H: 2.46% C: -0.23%
AMRS | $0.05 -21.88% -16.36% 47M

| -99.56% | O: -2.0% H: 0.49% C: -8.46%
covid partnership vaccine covid-19

56%

44%

CZOO | $10.52 110.82% 10M

CSSE 4 | $0.3181 108.86% 170M

BOF | $1.88 60.68% 98M

AMST | $3.1 55.0% 66M

LICN | $0.8592 53.43% 13M

WIMI | $1.03 41.99% 15M

MULN | News | $3.675 34.62% 11M

RILY | $28.605 31.7% 9.9M

RBBN 4 | $3.305 28.6% 1.9M

RCAT | $1.53 27.5% 2.9M

Save your searches and get alerts when important news are released.